CM Stock Price TSX Today: CIBC Buy or Sell Forecast

Canadian Imperial Bank of Commerce (TSX: CM) presents a paradox: 7 of 11 analysts rate it a Buy, yet the average target of C$152.86 points to a mere 1.58% upside from the current C$150.49 — and competing forecasts range from C$111 to C$167. This article resolves the conflicting analyst signals.

Current price (TSX): C$150.49 · Analyst consensus: 11 analysts, average target C$152.86 · Rating mix: 7 Buy / 4 Hold · Implied upside: +1.58%

What is the stock price of TSX CM today?

As of the most recent trading session tracked by MarketBeat, Canadian Imperial Bank of Commerce shares on the TSX are trading at C$150.49. That price represents the baseline against which analyst targets are measured — the average 12-month target of C$152.86 implies a modest 1.58% upside, though individual estimates range from C$141.00 on the low side to C$163.00 on the high side.

Not all data sources agree. TradingView lists 13 analysts and presents two conflicting forecast snapshots: one with a target of C$111.69 (max C$118, min C$104) and another with a target of C$155.35 (max C$167, min C$141). The discrepancy likely reflects different time horizons or data cuts.

The key metrics are summarized in the table below.

The implication: the only firm data point is the current price; future estimates are wide enough to accommodate very different outcomes.

Why are CIBC shares dropping?

Short-term price action offers a mixed picture. According to StockInvest.us, CM fell 0.188% on July 23, 2025, moving from US$74.42 to US$74.28 (that data appears in U.S. dollars, likely reflecting the NYSE listing). Over the prior two weeks as of that date, the stock was up 2.12% and had risen in six of the last ten trading days. Those numbers don’t signal a sharp drop — they suggest a stock that’s drifting with the broader market.

Broader sector concerns may weigh on sentiment. The Canadian banking industry faces headwinds from interest rate uncertainty and periodic consolidation rumors. While no specific “drop” is evident in the sourced data, the spread between analyst targets indicates that the market lacks a clear consensus on CIBC’s near-term trajectory. According to Simply Wall St, price targets were actually lifted into a C$135–C$158 range after Q1 results exceeded expectations, which suggests the earnings news was positive rather than negative.

For investors watching for a drop, the current price is within spitting distance of the low end of the MarketBeat target range (C$141), but still above the simply wall st range. The implication: any “drop” narrative is not supported by the recent earnings momentum — the stock is more range-bound than falling.

Is CM a good buy now?

MarketBeat’s consensus of 7 Buy and 4 Hold ratings from 11 analysts leans positive. The average target of C$152.86 implies a 1.58% upside from C$150.49 — a small but positive expected return. However, TradingView’s lower forecast set (C$111.69) would imply a 25% downside, while its higher set (C$155.35) suggests 3.2% upside. The spread is enormous.

For a decision-oriented reader, the question is about the source you trust. MarketBeat’s panel is more established and its numbers internally consistent. TradingView’s data may include different brokers or older surveys. Also, simply Wall St’s target range (C$135–C$158) sits squarely in the middle. According to TickerNerd, 7 Wall Street analysts give a bullish consensus with a median price target of US$109.17, implying 1.6% upside from its US$107.49 quote. That’s directionally similar to MarketBeat’s view, albeit in USD.

The catch: TickerNerd’s analyst mix is internally inconsistent (it claims 7 analysts but lists 8 Buy, 5 Hold, 1 Sell elsewhere on the page), so its data should be interpreted with caution.

The pattern: the decision to buy today hinges on accepting the current range-bound uncertainty rather than expecting a clear catalyst in the near term.

What is the future outlook for CM?

Looking ahead, the data points in different directions. Simply Wall St says CM is forecast to deliver a future return on equity of 15.3% in three years. That’s a strong profitability indicator for a bank. The same source notes the stock is up 57% over the past year — a figure that suggests considerable momentum, though that gain may partly reflect a recovery from earlier lows.

StockInvest.us projected a 21.27% rise over the next three months from its July 23 analysis. That’s an aggressive short-term call based on technical analysis rather than fundamentals. The same service assigned a stop-loss of US$71.55, implying a -3.67% downside risk from its reference price. The 3-month projection and the stop-loss together suggest high near-term volatility.

From a macro perspective, the Bank of Canada’s interest rate trajectory will play a dominant role in CIBC’s net interest margin. Rising rates historically benefit banks, but a slowing economy could pressure loan growth and asset quality. While this is general sector knowledge, the specific impact on CM is not quantified in the sourced data.

For the most bullish scenario — Simply Wall St’s 15.3% ROE plus StockInvest.us’s 21% short-term projection — the stock could trend toward the upper end of analyst ranges. For the bearish scenario — TradingView’s low target of C$111.69 — there’s substantial downside. The spread reflects genuine uncertainty.

What is the best Canadian bank stock to buy right now?

CIBC is one of Canada’s Big Six banks, traded on the TSX under CM. Compared to peers like TD (TD.TO) and RBC (RY.TO), CIBC’s valuation is in line with the sector, though precise comparisons require current P/E and dividend data that are not available in the sourced materials. What can be said: based on MarketBeat’s data, CM carries a majority Buy rating, which is a positive signal relative to a “Hold” consensus on some other banks in this rate cycle.

Simply Wall St notes that CIBC’s price targets were recently lifted after a Q1 earnings beat, giving it a near-term catalyst that some peers may lack. However, without side-by-side analyst coverage data for other banks, we cannot rank CIBC as definitively the best. The rational move for an investor is to compare CIBC’s 15.3% forecast ROE, current yield (not sourced), and target upside against the same metrics for TD, RBC, and BNS — all of which are beyond the scope of this article’s sourced data.

What this means: CM is a credible contender in the Canadian banking space, supported by positive earnings momentum and a favorable analyst consensus, but it’s not obviously the best pick without a peer comparison table.

Timeline signal

Two recent events stand out. On July 23, 2025, StockInvest.us upgraded CM from Hold/Accumulate to Buy Candidate, citing recent trading momentum. Separately, after CIBC’s Q1 2025 earnings results exceeded consensus, Simply Wall St reported that analyst price targets were lifted into a C$135 to C$158 range. Both signals point to improving sentiment, albeit from independent data services with tier-3 authority.

The pattern: the stock is gaining positive attention from two different analytical angles — technical (StockInvest.us) and fundamental (Simply Wall St). For a trader, the July 23 upgrade may be a near-term catalyst. For a longer-term investor, the earnings-driven target lift is the more substantial signal.

Clarity section

The pattern: confirmed facts outweigh unclear items in count, but the uncertainty around price targets remains the central tension for investors.

Quotes section

MarketBeat reports that 7 of 11 analysts rate CM a Buy and 4 rate it a Hold, with an average price target of C$152.86.

MarketBeat analyst consensus

TradingView lists 13 analysts offering one-year price forecasts, with two conflicting target sets — one at C$111.69 and another at C$155.35.

TradingView analyst survey

For Canadian investors weighing a position in CIBC, the decision comes down to which data set you trust. The MarketBeat consensus is more optimistic and consistent; the TradingView data introduces a wide, unsettling spread. The stock’s recent earnings momentum and technical upgrade give bulls ammunition, but the lack of a unified analyst outlook demands caution. For the prudent buyer, the choice is clear: watch for the next earnings report and a narrower target range before committing new capital, or accept the current uncertainty in exchange for a potential modest upside.

The decision to buy CM for income or growth ultimately depends on the investor’s trust in the analyst consensus and tolerance for conflicting forecasts.